Navigation Links
year in Biological Technology

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today reported results for the first quarter fiscal year 2010, ended June 30, 2009. Total revenue for the quarter was $5,061,000 compared to total revenue of $13,660,000 for the first quarter of fiscal ye...

Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009

MINNEAPOLIS, Aug. 4 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH ) consolidated net earnings for the quarter ended June 30, 2009 decreased 6.9% to $25.4 million or $.68 per diluted share compared with $27.3 million or $.70 per diluted share for the quarter ended June 30...

Bionovo, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Monday, August 10, 2009

EMERYVILLE, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ) announced today that it will release financial results for the second quarter of fiscal year 2009 ended June 30, 2009 on Monday, August 10, 2009. The Company will conduct a conference call and web cast t...

Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results

WALTHAM, Mass., July 30 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, August 6th, 2009 at 10:00 a.m. EDT, to report fi...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

ST. LOUIS, July 23 /PRNewswire-FirstCall/ --Sigma-Aldrich Corporation (Nasdaq: SIAL ), a leading Life Science and High Technology company, reported second quarter 2009 diluted EPS of $0.68 compared to $0.70 in the second quarter of 2008. For the six months ended June 30, 2009, reporte...

Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results

PALO ALTO, Calif., July 21,/PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) plans to release its financial results for the third quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, July 29, 2009. A live webcast (in listen-only mode) of its investor conf...

China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results

SHANGHAI, July 15 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financial results for t...

PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call

BOSTON, July 13 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ) will release Fourth Quarter and Fiscal Year 2009 financial results on Monday, August 10, 2009 after the close of the stock market. The announcement will be available on PAREXEL's website at www...

China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results

SHANGHAI, July 10 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the research, development, manufacture, marketing and distribution of probiotics dietary supplements, today announced it will host a c...

Kewaunee Scientific Reports Record Results Net Earnings for Year Increase 36%, Sales Increase 16%

STATESVILLE, N.C., June 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU ) today reported record sales, earnings, and order backlog for its fiscal year ended April 30, 2009. Net earnings for the year increased 36% to $4,247,000, or $1.66 per diluted share, up from...

Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results

WALTHAM, Mass., June 11 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today reported results for the fourth quarter and fiscal year 2009, ended March 31, 2009. Total revenue for fiscal year 2009 was $29,362,000 compared to total revenue of $19,296,000 for fiscal year 2008 ended...

Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results

Thursday, June 11th, 10:00 a.m. EDT WALTHAM, Mass., June 4 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, June 11th, 2009 a...

Shire begins the year with a strong performance

PHILADELPHIA and DUBLIN, April 30 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) the global specialty biopharmaceutical company, announces results for the three months to March 31, 2009. Financial Highlights ...

Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets

PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today reported earnings for its first quarter ended March 31, 2009 of $0.63 per diluted share versus $0.76 per diluted share in the first quarter of 2008 (or $0.73 per diluted share after excluding the centralized ECG ...

2008 a Record Year for Gerresheimer

DUSSELDORF, Germany, April 29 /PRNewswire-FirstCall/ -- - Strong Focus on the Markets of Pharma & Life Science - Annual General Meeting Passes Dividend of EUR0.40 per Share The Annual General Meeting of Gerresheimer AG today passed an unchanged dividend of EUR0.40 per ...

Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009

MINNEAPOLIS, April 28 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH ) consolidated net earnings for the quarter ended March 31, 2009 decreased 6.6% to $27.6 million or $.74 per diluted share compared with $29.6 million or $.76 per diluted share for the quarter ended March 31, 2008...

PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results

- Consolidated service revenue of $264.5 million grows 7.8% year-over-year - Operating margin of 10.0% - Diluted earnings per share of $0.25 - Net quarterly book-to-bill ratio equates to 1.25 BOSTON, April 27 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: ...

China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results

CHANGCHUN, China and LOS ANGELES, April 23 /PRNewswire-Asia-FirstCall/ -- - Fourth Quarter 2008 Revenue Increased 28.6% to $14.1 Million, with Net Income was $0.9 Million and Diluted EPS of $.03 - 2008 Revenues Increased 23.5% to $59.1 Million vs. 2007 - 2008 Gross Profit ...

Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards

SINGAPORE, April 21 /PRNewswire-Asia/ -- Moleac has been named the Singapore Entrepreneurial Company of the Year, by Frost & Sullivan. This award recognizes companies that have pushed the boundaries of excellence in the healthcare industry and acknowledges Moleac's outstanding performance ...

China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results

HARBIN, China, April 15 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced record ...

China Sky One Medical, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Results

HARBIN, China, April 15 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that it...

Varian, Inc. to Webcast Conference Call on Second Quarter Fiscal Year 2009 Financial Results

PALO ALTO, Calif., April 15 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) plans to release its financial results for the second quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, April 29, 2009. A live webcast (in listen-only mode) of its investor conference ...

Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008

BOLZANO, Italy, April 14 /PRNewswire/ -- Health Robotics today announced audited results for FY2008 ending December 31, 2008, delivering record levels of firm purchase orders, revenue, earnings and cash flow. Revenues in FY2008 were EUR8.2 million, a 161% increase year-over-year as the ...

OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia

BOTHELL, WA, and VANCOUVER, April 9 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ), announced today that it has been named the 2009 Life Sciences Company of the Year by LifeSciences British Columbia. This annual award is presented by LifeS...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables

BEIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, today announced the Company's unaudited financial results for the three and twelve month periods ended December 31, 2008. Full Year 2008 Financial High...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results

BEIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, today announced the Company's unaudited financial results for the three and twelve month periods ended December 31, 2008. Full Year 2008 Financial High...

ChromaDex Announces 2008 Year End Financial Results

IRVINE, Calif., April 3 /PRNewswire-FirstCall/ -- ChromaDex Corporation, (OTC Bulletin Board: CDXC) a leader in phytochemical reference standards and contract research, today announced financial results for the 2008 Fiscal Year. On a reported basis calculated in accordance with U.S. Generally Acce...

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results

2008 and Recent Events Highlighted EMERYVILLE, Calif., April 1, /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical company developing first-in-class anti-infective products for the treatment and prevention of a wide range of infections w...

Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results

BEIJING, April 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Amex: SVA ), a leading provider of vaccines in China, today announced that it will host a conference call on Thursday, April 9, 2009 at 9:00 a.m. ET (9 p.m. China Standard Time) to review the Company's financial results for the four...

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results

LYNBROOK, N.Y., March 30 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2008. "We are ...

TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results

LA JOLLA, Calif., March 27 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced financial results for the fourth quarter and year ended December 31, 2008. For the full year 2008, the Company posted revenue of $6.1 million and a net loss of $22.8 million. Cash and ca...

International Isotopes Inc. Announces Year End Financial Results

Company Shows a 19% Increase In Total Revenue To $5.6 Million; 34% Increase in Gross Profit IDAHO FALLS, Idaho, March 27 /PRNewswire-FirstCall/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) announces the financial results for fiscal year ended December 31, 2008. Total Re...

Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results

CARY, N.C., March 26 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory market, today reported financial results for the year ended Dec...

ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today reported financial results for the fourth quarter and year ended December 31, 2008. "2008 was a transition year for ADVENTRX in which we advanced a new business model focused on lower-risk r...

Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results

OMAHA, Neb., March 18 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced financial results for the fourth quarter and year ended December 31, 2008. The Company's financial results are presented in the tables that follow. Fourth Quarter 2008 The Company...

BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results

PLYMOUTH MEETING, Pa., March 17 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP ) ("BMP Sunstone" or the "Company"), today announced financial results for the fourth quarter and fiscal year ended December 31, 2008. Financial Highlights as of December 31, 2008: ...

BioMS Medical Announces 2008 Year End Results

Toronto Stock Exchange Symbol: MS EDMONTON, March 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the year ended December 31, 2008. "Dirucotide has demonstrated ...

AutoImmune Inc. Reports 2008 Fourth Quarter and Year End Financial Results

PASADENA, Calif., March 16 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Bulletin Board: AIMM) today reported a net loss of $129,000, or $0.01 per share basic and diluted, for the three months ended December 31, 2008, compared with a net loss of $56,000, or break even per share basic and diluted,...

Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results

Net operating expenses decreased by 33% in 2008; Forecast cutting net operating expenses by approximately 50% in 2009 CTI expects to complete pixantrone NDA submission in Q2 2009 SEATTLE, March 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today repo...

Dendreon Reports Fourth Quarter and 2008 Year End Financial Results

SEATTLE, March 12 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today reported results for the year and quarter ended December 31, 2008. Revenues for the year ended December 31, 2008 were $111,000 compared to $743,000 for the year ended December 31, 2007. Revenues for the fourth...
Other Tags
(Date:7/24/2014)... electric cars ply silent freeways, solar panels blanket rooftops ... earth, from howling winds and from the blazing desert ... is technically and economically feasible to convert California,s all-purpose ... Published in Energy , the plan shows the ... in California that could create tens of thousands of ...
(Date:7/24/2014)... brewery has its own microbial terroir, meaning the microbial ... found in the product, creating the final flavor according ... Applied and Environmental Microbiology . This is the ... a sake brewery. , Many sake makers inoculate ... A. Mills of the University of California, Davis, but ...
(Date:7/24/2014)... low vision specialist at The University of Texas Health ... awarded a grant to help Harris County residents whose ... surgery. , Even with corrective lenses, many people with ... are a variety of low vision devices, such as ... vision loss. , Iyer is using the three-year, $164,645 ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4The microbes make the sake brewery 2UTHealth Dr. Bhavani Iyer awarded low vision grant 2
(Date:7/25/2014)... The European Society for Medical Oncology (ESMO), the ... expressed concern that the proposed EU General Data ... and add a significant burden to both doctors ... the regulation [2] stipulates ,explicit and specific patient ... patients every single time research is planned in ...
(Date:7/25/2014)... Yisrayl Hawkins, Pastor and Overseer of The House of Yahweh ... revealing to the whole world, including even the most devout ... in his new article. , Yisrayl says it all started ... by the Catholic Church. He says this plan included removing ... and replacing it with titles such as Lord and God. ...
(Date:7/25/2014)... 2014 According to the Addict Him To ... comprehensive dating guide that teaches women how to get the ... reveals in its review that this book consists of 4 ... your man won’t commit yet (and what to do about ... want you ,     Part 3: How to touch ...
(Date:7/25/2014)... At World T.E.A.M. Sports’ Adventure ... participating developmentally-disabled teens and young adults discovered that outdoor ... canoeing and hiking can be challenging. , The third-year ... Chesapeake and Ohio Canal National Historical Park , ... and able-bodied. Under slightly overcast skies and temperatures in ...
(Date:7/24/2014)... A few weeks have passed since USA Track ... by Inika McPherson is a feat to continue celebrating. ... Championships hosted the best track and field athletes competing ... Nationals with the 2nd best jump in the world ... height over head jump in history. , Zensah® is ...
Breaking Medicine News(10 mins):Health News:Is Europe putting cancer research at risk? 2Health News:Yisrayl Hawkins Says You Have Been Tricked Into Worshipping Satan in New Article 2Health News:Addict Him To You Pdf Review Exposes Mirabelle Summers' Dating Guide – Vkool.com 2Health News:Addict Him To You Pdf Review Exposes Mirabelle Summers' Dating Guide – Vkool.com 3Health News:DC Adventure Team Challenge Thrills Developmentally-Disabled Participants 2Health News:DC Adventure Team Challenge Thrills Developmentally-Disabled Participants 3Health News:Setting A New High Jump World Record In Zensah® Compression 2Health News:Setting A New High Jump World Record In Zensah® Compression 3
Other Contents